Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Topotecan in Persistent or Recurrent Cervical Cancer
NCT00087126Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Feb 2005
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in Cervical Cancer (CC), sponsored by GOG Foundation. Started Feb 2005; status: completed.
02
Drugs
topotecan
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00087126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087126.